|
Blue Cross Blue Shield of Michigan launched a new Chronic Condition Management Program for Diabetes in June to provide eligible Medicare members with Type 1 or Type 2 diabetes personalized and coordinated support.
Patient eligibility
The program targets Medicare PPO and Blue Care Network Advantage patients with HbA1c values of 9 or greater and who are not in full-risk arrangements. Members are identified using claims and lab data.
Program design
Participating patients receive 1:1 support from a dedicated care team that includes registered nurses and health coaches who are certified diabetes educators. Through telephonic assessment and collaborative care plan development, the team provides condition-specific education and lifestyle coaching to decrease A1c, decrease care gaps and improve medication adherence. The Blue Cross Chronic Condition Management team will coordinate care with the members’ primary care providers, specialists and other resources when appropriate.
Teladoc diabetes management program ends
As the new program gets underway, the Teladoc Diabetes Management Program will end for Medicare patients on August 31, 2026. After that date, Teladoc diabetes coaching, remote monitoring and account access will end. Patients can continue to use a Teladoc glucose monitor as long as they have Teladoc test strips, but they should talk with their primary care providers about switching to diabetes monitoring supplies that best fit their ongoing care needs and that are covered by their benefit plans.
A key enhancement of the Blue Cross program is the inclusion of eligible patients who use continuous glucose monitors. Expanding program eligibility to members who use a broader range of diabetes monitoring devices allows more members to receive condition-specific education and support that complement their provider-directed treatment plans. When continuous glucose monitoring is deemed clinically appropriate by the patient’s provider, Blue Cross aims to ensure these members also have access to coordinated diabetes management support.
Transition plans
Blue Cross reached out to all current Teladoc-engaged patients from June through August 2026 to inform them of this change. Those also eligible for the new Blue Cross program will be encouraged to participate.
Contact
If you’re working with a Medicare Advantage patient who has diabetes, an HbA1c of 9 or higher and could benefit from additional diabetes support, please contact Blue Cross at 800-775-2583.
| 
